A more recent study using [11C]flumazenil (FMZ) PET has been performed by Turner et al. [44], who focalized their interest in patients with ALS, also including subjects who presented the “D90A” SOD1 mutation. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.